Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Indaptus Therapeutics, Inc. (INDP)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
10 Aug 2023
Anderson Glen R.
10% Owner
Indaptus Therapeutics, Inc.
(INDP)
1,190,400
+9%
103,352
$2.09
$216,388.00
BUY
18 Nov 2022
Meckler Jeffrey A
CEO and Director, Director, Officer
Indaptus Therapeutics, Inc.
(INDP)
75,374
+15%
10,000
$1.89
$18,945.48
BUY
8 Sep 2022
Meckler Jeffrey A
CEO and Director, Director, Officer
Indaptus Therapeutics, Inc.
(INDP)
65,374
+18%
10,308
$2.80
$28,862.40
BUY
7 Sep 2022
Linscott Walt Addison
Chief Business Officer, Officer
Indaptus Therapeutics, Inc.
(INDP)
150
+100%
150
$2.62
$393.00
BUY
6 Sep 2022
Meckler Jeffrey A
CEO and Director, Director, Officer
Indaptus Therapeutics, Inc.
(INDP)
55,066
+21%
9,692
$2.56
$24,770.64
BUY
6 Jun 2022
Meckler Jeffrey A
CEO and Director, Director, Officer
Indaptus Therapeutics, Inc.
(INDP)
45,374
+76%
19,727
$2.63
$51,882.01
SELL
31 Jan 2022
Newman Michael James
CSO and Director, Director, Officer, 10% Owner
Indaptus Therapeutics, Inc.
(INDP)
1,368,356
-1%
20,000
$5.00
$100,042.98
BUY
31 Jan 2022
Litchev Boyan Vesselinov
Chief Medical Officer, Officer
Indaptus Therapeutics, Inc.
(INDP)
1,150
+100%
1,150
$2.19
$2,520.08
BUY
18 Nov 2021
Meckler Jeffrey A
CEO and Director, Director, Officer
Indaptus Therapeutics, Inc.
(INDP)
25,647
+77%
11,187
$5.82
$65,108.34
BUY
14 Sep 2021
Meckler Jeffrey A
CEO and Director, Director, Officer
Indaptus Therapeutics, Inc.
(INDP)
14,460
+487%
12,000
$7.00
$84,000.00
Home